2304P A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19 -17)

Annals of Oncology(2023)

引用 0|浏览4
暂无评分
关键词
advanced solid cancers,tepotinib,mutations
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要